Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

New England Journal of Medicine - Tập 352 Số 26 - Trang 2682-2695 - 2005
George Lau1, Teerha Piratvisuth2, K.X. Luo3, Patrick Marcellin4, Satawat Thongsawat5, Graham Cooksley6, Edward Gane7, Michael Fried8, Wan Cheng Chow9, Seung Woon Paik10, Wen Yu Chang11, Thomas Berg12, Robert Flisiak13, Philip McCloud14, N. Pluck15
1Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China
2Department of Medicine, Songklanakarin Hospital, Songkla, Thailand
3Department of Infectious Diseases, Nangfang Hospital, Guangzhou, China
4Service d'Hépatologie, INSERM Unité 481 and Centre de Recherches Claude Bernard sur les Hépatites Virales, Hôpital Beaujon, Clichy, France
5Department of Internal Medicine, Chiang Mai University, Chiang Mai, Thailand
6Clinical Research Department, Royal Brisbane Hospital, Herston, Australia
7Gastroenterology Department, Middlemore Hospital, Otahuhu, New Zealand
8University of North Carolina Liver Program, University of North Carolina, Chapel Hill
9Gastroenterology Department, Singapore General Hospital, Singapore
10Division of Gastroenterology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
11Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
12Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Charité, Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin
13Department of Infectious Diseases, Medical University of Bialystok, Bialystok, Poland
14Roche, Dee Why, Australia
15Roche, Welwyn, United Kingdom

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1016/S0140-6736(03)15108-2

de Franchis R, 2003, J Hepatol, 39, S3

10.1111/j.1478-3231.2005.01134.x

10.1002/hep.20110

10.1002/hep.1840060203

10.1056/NEJM199605303342202

10.1056/NEJM199807093390201

10.1056/NEJM199910213411702

10.1056/NEJMoa020681

10.1136/gut.46.4.562

10.1016/S0168-8278(04)90057-8

10.1016/S0168-8278(03)00155-7

10.1016/S0168-8278(01)00145-3

10.1016/S0168-8278(02)00056-9

10.1021/bc000082g

10.2165/00003495-200161150-00013

10.1046/j.1365-2893.2003.00450.x

10.1016/0168-8278(95)80226-6

10.1128/JCM.40.10.3729-3734.2002

10.1016/S0168-8278(03)00154-5

10.1046/j.1440-1746.2003.02976.x

Yuen MF, 2003, Antivir Ther, 8, 531, 10.1177/135965350300800610

10.1016/S0016-5085(03)00700-5

10.1046/j.1440-1746.2002.02737.x

10.1016/S0140-6736(05)17701-0

10.1056/NEJM199008023230503

10.1053/jhep.2000.18194

10.1056/NEJMoa040431

10.1111/j.1572-0241.1998.00272.x

10.1016/S0140-6736(88)92355-0

Lok AS, 1993, Gastroenterology, 105, 1833, 10.1016/0016-5085(93)91082-S

Tangkijvanich P, 2001, Southeast Asian J Trop Med Public Health, 32, 452

10.1056/NEJM200012073432301

10.1056/NEJMoa020047